Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Onc.AI, a digital health company developing AI-powered oncology clinical management solutions, today announced that new validation study results from research collaborations with Pfizer, Baylor Scott ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the presentation of two new abstracts at the 2025 American Society of ...

Biognosys, a global leader in mass spectrometry-based proteomics solutions, announces the launch of Spectronaut® 20 and SpectroMine™ 5 at the ASMS 2025 Annual Conference, taking place June 1–5 in ...

The department of biochemistry, Father Muller Medical College, Kankanady, hosted the inauguration of the 10th annual state ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

The University event for early-career researchers and creators to present their work celebrated its 10th anniversary.

The leading corneal research presented at ASCRS offered a glimpse at the subspecialty’s most promising medical and surgical advancements.

Pet care is booming and veterinary medicine isn’t plan B anymore. But colleges are still teaching students how to treat ...